EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 -1.874
December 31, 2024 -4.002
December 31, 2023 -0.1456
December 31, 2022 -0.2636
December 31, 2021 0.0192
December 31, 2020 -0.0475
December 31, 2019 -0.0664
December 31, 2018 -0.3911
December 31, 2017 -0.2527
December 31, 2016 -0.4072
December 31, 2015 -16.57
December 31, 2014 -0.36
December 31, 2013 -1.282
December 31, 2012 -1.246
Date Value
December 31, 2011 -0.5323
December 31, 2010 -2.489
December 31, 2009 -1.400
December 31, 2008 -0.9216
December 31, 2007 -3.897
December 31, 2006 -64.93
December 31, 2005 -88.05
December 31, 2004 2.066
December 31, 2003 -11.25
December 31, 2002 -37.35
December 31, 2001 -0.7198
December 31, 2000 0.605
December 31, 1999 2.911
December 31, 1998 -1.328

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 4.669
Alkermes Plc 1.432
Cellectis SA -0.6761
Akari Therapeutics Plc -20.60
Liquidia Corp. -0.8009